Chemclin Diagnostics Co., Ltd. (688468.SS) SHH

7.74

+0.1(+1.31%)

Updated at September 30 01:24PM

Currency In CNY

Valuation

Market Cap2.72B
Enterprise Value2.54B
P/E Ratio37.49
PEG Ratio-1.45
Price/Sales Ratio8.11
Price/Book Ratio2.01
Enterprise/Revenue7.44
Enterprise/EBITDA33.64

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.2
Operating Margin0.21

Management Effectiveness

Return On Assets0.04
Return On Equity0.05

Income Statement

Revenue436.29M
Revenue/Share1.03
Gross Profit323.17M
EBITDA196.86M
Net Income127.07M
Diluted EPS0.32

Balance Sheet

Total Cash853.65M
Total Cash/Share2.35
Total Debt229.06M
Total Debt/Equity0.16
Current Ratio7.1
Book Value Per Share3.83

Price History

52-Week Change10.46
52-Week High9.12
52-Week Low6.04
Moving Average 50 Days8.2
Moving Average 200 Days7.5

Statistics

Average Volume7.71M
Shares Outstanding394.66M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.13
Trailing Annual Dividend Yield1.62
Payout Ratio0.75
Last Split FactorN/A
Last Split DateN/A